Prediction of vancomycin dose on high-dimensional data using machine learning techniques

References

• Rybak M, Lomaestro B, Rotschafer JC, et al., Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm. 66(1): 82–98. 2009. .
   PubMedGoogle Scholar
• Rybak MJ, Le J, Lodise TP, et al., Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: a revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm. 77(11): 835–864. 2020. .
   PubMed Web of Science ®Google Scholar
• Gyssens IC. Kucers’ the Use of Antibiotics. London: Hodder Arnold; 2010.
   Google Scholar
• Health Communication Network. Australian Medicines Handbook. Adelaide, SA: Australian Medicines Handbook; 2012.
   Google Scholar
• Klevens RM, Morrison MA, Nadle J, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA. 2007;298(15):1763–1771. .
   PubMed Web of Science ®Google Scholar
• Cassini A, Högberg LD, Plachouras D, et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. Lancet Infect Dis. 2019;19(1):56–66. .
   PubMed Web of Science ®Google Scholar
• Wunderink RG, Niederman MS, Kollef MH, et al. Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study. Clin Infect Dis. 2012;54(5):621–629.
   PubMed Web of Science ®Google Scholar
• Álvarez R, López Cortés LE, Molina J, et al. Optimizing the clinical use of vancomycin. Antimicrob Agents Chemother. 2016;60(5):2601–2609.
   PubMed Web of Science ®Google Scholar
• Elyasi S, Khalili H. Vancomycin dosing nomograms targeting high serum trough levels in different populations: pros and cons. Eur J Clin Pharmacol. 2016;72(7):777–788.
   PubMed Web of Science ®Google Scholar
• Pai MP, Neely M, Rodvold KA, et al. Innovative approaches to optimizing the delivery of vancomycin in individual patients. Adv Drug Deliv Rev. 2014;77:50–57.
   PubMed Web of Science ®Google Scholar
• Braig D, Nero TL, Koch HG, et al. Transitional changes in the CRP structure lead to the exposure of proinflammatory binding sites. Nat Commun. 2017;8(1):14188. .
   PubMedGoogle Scholar
• Mackett RL, Guay DR. Vancomycin-induced neutropenia. Can Med Assoc J. 1985;132(1):39–40.
   PubMed Web of Science ®Google Scholar
• Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol. 2018;9:754.
   PubMed Web of Science ®Google Scholar
• Chantziara V, Georgiou S, Tsimogianni A, et al. The predictive role of C-reactive protein and procalcitonin biomarkers in central nervous system infections with extensively drug resistant bacteria. Crit Care. 2016;20(Suppl 2): P013.
   PubMedGoogle Scholar
• Deresinski S. Vancomycin in Combination with Other Antibiotics for the Treatment of Serious Methicillin-Resistant Staphylococcus aureus Infections. Clin Infect Dis. 2009;49(7):1072–1079.
   PubMed Web of Science ®Google Scholar
• Chen T, Guestrin C XGBoost: a scalable tree boosting system. In: Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining. San Francisco, CA, ACM, 2016:785–794.
   Google Scholar
• Denny JC, Van Driest SL, Wei WQ, et al. The influence of big (clinical) data and genomics on precision medicine and drug development. Clin Pharmacol Ther. 2018;103(3):409–418.
   PubMed Web of Science ®Google Scholar
• Linden A, Yarnold PR, Nallamothu BK. Using machine learning to model dose-response relationships. J Eval Clin Pract. 2016;22(6):856–863.
   PubMed Web of Science ®Google Scholar
• Lundberg SM, Lee SI. A unified approach to interpreting model predictions. In: Advances in Neural Information Processing Systems. Long Beach, CA: Neural Information Processing Systems; 2017. p. 4765–4774.
   Google Scholar
• Shin J, Cao D. Comparison of warfarin pharmacogenetic dosing algorithms in a racially diverse large cohort. Pharmacogenomics. 2011;12(1):125–134.
   PubMed Web of Science ®Google Scholar
• Colin PJ, Allegaert K, Thomson AH, et al. Vancomycin pharmacokinetics throughout life: results from a pooled population analysis and evaluation of current dosing recommendations. Clin Pharmacokinet. 2019;58(6):767–780.
   PubMed Web of Science ®Google Scholar
• De Velde F, Mouton JW, De Winter BCM, et al. Clinical applications of population pharmacokinetic models of antibiotics: challenges and perspectives. Pharmacol Res. 2018;134:280–288.
   PubMed Web of Science ®Google Scholar
• Batzel JJ, Hinghofer-Szalkay H, Kappel F, et al. Bridging different perspectives of the physiological and mathematical disciplines. Adv Physiol Educ. 2012;36(4):265–274.
   PubMed Web of Science ®Google Scholar
• Moellering RC Jr, Krogstad DJ, Greenblatt DJ. Vancomycin therapy in patients with impaired renal function: a nomogram for dosage. Ann Intern Med. 1981;94(3):343–346.
   PubMed Web of Science ®Google Scholar
• Roberts JA, Taccone FS, Udy AA, et al. Vancomycin dosing in critically ill patients: robust methods for improved continuous-infusion regimens. Antimicrob Agents Chemother. 2011;55(6):2704–2709.
   PubMed Web of Science ®Google Scholar
• Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31–41.
   PubMed Web of Science ®Google Scholar
• Hall RG 2nd, Payne KD, Bain AM, et al. Multicenter evaluation of vancomycin dosing: emphasis on obesity. Am J Med. 2008;121(6):515–518.
   PubMed Web of Science ®Google Scholar
• Young T, Daniel M, Baumhover S, et al. Methodological study of vancomycin dosing in elderly patients using actual serum creatinine versus rounded serum creatinine. Drugs R D. 2017;17(3):435–440.
   PubMed Web of Science ®Google Scholar
• Pritchard L, Baker C, Leggett J, et al. Increasing vancomycin serum trough concentrations and incidence of nephrotoxicity. Am J Med. 2010;123(12):1143–1149.
   PubMed Web of Science ®Google Scholar
• Hidayat LK, Hsu DI, Quist R, et al. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity. Arch Intern Med. 2006;166(19):2138–2144.
   PubMedGoogle Scholar
• Lodise TP, Lomaestro B, Graves J, et al. Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity. Antimicrob Agents Chemother. 2008;52(4):1330–1336.
   PubMed Web of Science ®Google Scholar
• Jeffres MN, Isakow W, Doherty JA, et al. A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia. ClinTher. 2007;29(6):1107–1115.
   Google Scholar
• Giordano C, Karasik O, King-Morris K, et al. Uric acid as a marker of kidney disease: review of the current literature. Dis Markers. 2015;2015:382918.
   PubMed Web of Science ®Google Scholar
• Pan KM, Wu Y, Chen C, et al. Vancomycin-induced acute kidney injury in elderly Chinese patients: a single-centre cross-sectional study. Br J Clin Pharmacol. 2018;84(8):1706–1718.
   PubMed Web of Science ®Google Scholar
• Von Drygalski A, Curtis BR, Bougie DW, et al. Vancomycin-induced immune thrombocytopenia. N Engl J Med. 2007;356(9):904–910.
   PubMed Web of Science ®Google Scholar
• Butterfield JM, Patel N, Pai MP, et al. Refining vancomycin protein binding estimates: identification of clinical factors that influence protein binding. Antimicrob Agents Chemother. 2011;55(9):4277–4282.
   PubMed Web of Science ®Google Scholar
• Bhagwat SS, Nandanwar M, Kansagara A, et al. <p>Levonadifloxacin, a Novel Broad-Spectrum Anti-MRSA Benzoquinolizine Quinolone Agent: review of Current Evidence. Drug Des Devel Ther. 2019;13:4351–4365.
   PubMed Web of Science ®Google Scholar
• Goa KL, Barradell LB, Fluconazole. An update of its pharmacodynamic and pharmacokinetic properties and therapeutic use in major superficial and systemic mycoses in immunocompromised patients. Drugs. 1995;50(4):658–690.
   PubMed Web of Science ®Google Scholar
• Credito K, Lin G, Appelbaum PC. Antistaphylococcal activity of DX-619 alone and in combination with vancomycin, teicoplanin, and linezolid assessed by time-kill synergy testing. Antimicrob Agents Chemother. 2007;51(4):1508–1511.
   PubMed Web of Science ®Google Scholar
• Debruyne D, Ryckelynck JP. Clinical pharmacokinetics of fluconazole. Clin Pharmacokinet. 1993;24(1):10–27.
   PubMed Web of Science ®Google Scholar
• Garey KW, Pai MP, Suda KJ, et al. Inadequacy of fluconazole dosing in patients with candidemia based on Infectious Diseases Society of America (IDSA) guidelines. Pharmacoepidemiol Drug Saf. 2007;16(8):919–927.
   PubMed Web of Science ®Google Scholar
• Li L, Li X, Xia Y, et al. Recommendation of antimicrobial dosing optimization during continuous renal replacement therapy. Front Pharmacol. 2020;11:786.
   PubMed Web of Science ®Google Scholar
• Timpe EM. Nephrotoxicity with combination vancomycin-aminoglycoside therapy. J Pediatr Pharmacol Ther. 2005;10(3):174–182.
   PubMedGoogle Scholar
• Avent ML, Vaska VL, Rogers BA, et al. Vancomycin therapeutics and monitoring: a contemporary approach. Intern Med J. 2013;43(2):110‐9.
   PubMed Web of Science ®Google Scholar
• Baptista JP, Roberts JA, Sousa E, et al. Decreasing the time to achieve therapeutic vancomycin concentrations in critically ill patients: developing and testing of a dosing nomogram. Crit Care. 2014;18(6):654.
   PubMed Web of Science ®Google Scholar
• Imai S, Yamada T, Ishiguro N, et al. Validating the effectiveness of switching the vancomycin TDM analysis software based on the predictive accuracy. Yakugaku Zasshi. 2017;137(9):1185‐92.
   Web of Science ®Google Scholar
• Kullar R, Leonard SN, Davis SL, et al. Validation of the effectiveness of a vancomycin nomogram in achieving target trough concentrations of 15-20 mg/L suggested by the vancomycin consensus guidelines. Pharmacotherapy. 2011;31(5):441–448. .
   PubMed Web of Science ®Google Scholar
• Bayard DS, Jelliffe RW. A Bayesian approach to tracking patients having changing pharmacokinetic parameters. J Pharmacokinet Pharmacodyn. 2004;31(1):75‐107.
   PubMed Web of Science ®Google Scholar
• Macdonald I, Staatz CE, Jelliffe RW, et al. Evaluation and comparison of simple multiple model, richer data multiple model, and sequential interacting multiple model (IMM) Bayesian analyses of gentamicin and vancomycin data collected from patients undergoing cardiothoracic surgery. Ther Drug Monit. 2008;30(1):67‐74.
   PubMed Web of Science ®Google Scholar
• Aubron C, Corallo CE, Nunn MO, et al. Evaluation of the accuracy of a pharmacokinetic dosing program in predicting serum vancomycin concentrations in critically ill patients. Ann Pharmacother. 2011;45(10):1193‐8.
   Web of Science ®Google Scholar
• McClellan SD, Farringer JA. Bayesian forecasting of aminoglycoside dosing requirements in obese patients: influence of subpopulation versus general population pharmacokinetic parameters as the internal estimates. Ther Drug Monit. 1989;11(4):431–436.
   PubMed Web of Science ®Google Scholar
• Sharabiani A, Bress A, Douzali E, et al. Revisiting warfarin dosing using machine learning techniques. Comput Math Methods Med. 2015;2015:560108.
   PubMed Web of Science ®Google Scholar
• Cosgun E, Limdi NA, Duarte CW. High-dimensional pharmacogenetic prediction of a continuous trait using machine learning techniques with application to warfarin dose prediction in African Americans. Bioinformatics. 2011;27(10):1384–1389.
   PubMed Web of Science ®Google Scholar
• Tang J, Liu R, Zhang YL, et al. Application of machine-learning models to predict tacrolimus stable dose in renal transplant recipients. Sci Rep. 2017;7(1):42192.
   PubMedGoogle Scholar
• Kuhn M, Johnson K. Applied predictive modeling. New York: Springer-Verlag; 2013.
   Google Scholar
• James G, Witten D, Hastie T, et al. An introduction to statistical learning: with applications in R. New York: Springer-Verlag; 2013.
   Google Scholar
• Ting DSW, Cheung CY, Lim G, et al. Development and validation of a deep learning system for diabetic retinopathy and related eye diseases using retinal images from multiethnic populations with diabetes. JAMA. 2017;318(22):2211–2223.
   PubMed Web of Science ®Google Scholar
• Kolachalama VB, Singh P, Lin CQ, et al. Association of pathological fibrosis with renal survival using deep neural networks. Kidney Int Rep. 2018;3(2):464–475.
   PubMed Web of Science ®Google Scholar